CG Oncology, Inc. - Common Stock (CGON)

CUSIP: 156944100

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+1,805,282
Put/Call ratio
16%
SEC-reported price per share
$40.28
Number of holders
175
Value change
+$92,134,469
Number of buys
87
Open additional details 1 more signal available
Number of sells
75
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
88,583,765

Security key

156944100

Report period

Q3 2025

Institutions

175

Top holders

10

Ownership snapshot

Top reported holders of CGON - CG Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Decheng Capital Global Li...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 3/4/5 13F Lead comparable stake: 8.4% 13D/G row: Decheng Capital Global Life Sciences Fund IV, L.P. Showing 1-6 of 15 holder rows.

Quick read

Decheng Capital Global Life Sciences Fund IV, L.P. leads the comparable SEC ownership view at 8.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Decheng Capital Global Life Sciences Fund IV, L.P.'s linked filing trail.
Comparable ownership Top 5
Decheng Capital Global Life Scien... 8.4%
WELLINGTON MANAGEMENT GROUP LLP 7.2%
Longitude Capital Partners IV, LLC 6%
Unique Diamond Investments Ltd 5.5%
FMR LLC 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Decheng Capital Global Life Sciences Fund IV, L.P.
13D/G 3/4/5
Xiangmin Cui · 10%+ Owner
8.4%
$178,215,582
6,371,669 shares
$0 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP
13D/G 13F
Company
7.2%
$222,054,738
5,512,779 shares
$0 30 Sep 2025
Longitude Capital Partners IV, LLC
13D/G
Patrick G. Enright
6%
$121,032,477
4,662,268 shares
$0 11 Sep 2025
Unique Diamond Investments Ltd
13D/G
SONG, Hong Fang
5.5%
$117,791,208
4,211,341 shares
$0 31 Dec 2024
FMR LLC
13D/G 13F
Company
5.1%
$100,262,786
3,856,261 shares
$0 30 Jun 2025
TCG Crossover GP I, LLC
13D/G
4.8%
$102,655,662
3,670,206 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
175
Shares
77,648,888
Rows available
175
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
161
Q3 2025 holders
175
Holder diff
14
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .